- Home
- DERM vs PYXS Comparison
DERM vs PYXS Comparison
Compare DERM & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- PYXS
- Stock Information
- Founded
- DERM 2014
- PYXS 2018
- Country
- DERM United States
- PYXS United States
- Employees
- DERM N/A
- PYXS N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- DERM Health Care
- PYXS Health Care
- Exchange
- DERM Nasdaq
- PYXS Nasdaq
- Market Cap
- DERM 213.6M
- PYXS 243.5M
- IPO Year
- DERM 2021
- PYXS 2021
- Fundamental
- Price
- DERM $7.92
- PYXS $4.69
- Analyst Decision
- DERM Strong Buy
- PYXS Strong Buy
- Analyst Count
- DERM 3
- PYXS 4
- Target Price
- DERM $12.67
- PYXS $6.67
- AVG Volume (30 Days)
- DERM 256.5K
- PYXS 737.4K
- Earning Date
- DERM 11-12-2025
- PYXS 11-03-2025
- Dividend Yield
- DERM N/A
- PYXS N/A
- EPS Growth
- DERM N/A
- PYXS N/A
- EPS
- DERM N/A
- PYXS N/A
- Revenue
- DERM $59,399,000.00
- PYXS $2,820,000.00
- Revenue This Year
- DERM $26.16
- PYXS N/A
- Revenue Next Year
- DERM $45.27
- PYXS N/A
- P/E Ratio
- DERM N/A
- PYXS N/A
- Revenue Growth
- DERM 2.82
- PYXS N/A
- 52 Week Low
- DERM $3.54
- PYXS $0.83
- 52 Week High
- DERM $9.40
- PYXS $4.86
- Technical
- Relative Strength Index (RSI)
- DERM 48.07
- PYXS 68.39
- Support Level
- DERM $7.42
- PYXS $4.23
- Resistance Level
- DERM $9.40
- PYXS $4.64
- Average True Range (ATR)
- DERM 0.54
- PYXS 0.40
- MACD
- DERM -0.14
- PYXS 0.03
- Stochastic Oscillator
- DERM 27.53
- PYXS 88.61
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.